0.75 CME Credit
Managing Agitation in Alzheimer’s Dementia: Current and Future Approaches
0.75 AMA PRA Category 1 Credits, 0.75 ABIM MOC or 0.84 AANP
Release Date: 1/23/2023
Available for credit until 7/14/2024
- Discuss the epidemiology of agitation in Alzheimer’s dementia and its burden on patients, caregivers, and the healthcare system
- Recognize causes and clinical presentation of agitation in Alzheimer’s dementia
- Identify recommended nonpharmacological interventions for agitation in Alzheimer’s dementia
- Review the efficacy and tolerability of currently available pharmacotherapies for agitation in Alzheimer’s dementia
- Discuss the mechanism of action and available efficacy and safety data for emerging therapies for agitation in Alzheimer’s dementia
Agitation in Alzheimer’s Dementia: What’s at Stake
Is Agitation in Alzheimer’s Dementia Under-Recognized?
Nonpharmacological Approaches to the Treatment of Agitation in Alzheimer’s Dementia
Pierre N. Tariot, MD
Research Professor of Psychiatry
University of Arizona College of Medicine
Director, Banner Alzheimer’s Institute
Pallavi Joshi, DO, MA
Geriatric Psychiatrist, Banner Alzheimer’s Institute
Assistant Clinical Professor, University of Arizona, College of Medicine-Phoenix
Supporters and Partners
Otsuka America Pharmaceutical, Inc. and Lundbeck
Miller Medical Communications, LLC
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions? If you have questions about this activity, please email email@example.com or call (877) 477-4633.